In vivo antimalarial activity of self-nanoemulsifying drug delivery systems containing ethanolic extract of Morinda lucida in combination with other Congolese plants extracts

Abstract Morinda lucida leaves are largely used by Congolese traditional healers for the treatment of uncomplicated malaria. The antimalarial activity of their ethanolic extract has been confirmed both in vitro and in vivo. However, the development of relevant formulations for potential clinical application is hampered since the active ingredients contained in this extract exhibit poor water solubility and low oral bioavailability. Hence, this work aims not only to develop self-nanoemulsifying drug delivery systems (SNEDDSs) for oral delivery of the ethanolic extract of Morinda lucida (ML) but also to evaluate its oral antimalarial activity alone and in combination with other Congolese ethanolic plant extracts (Alstonia congensis, Garcinia kola, Lantana camara, Morinda morindoides or Newbouldia laevis). Based on the solubility of these different extracts in various excipients, SNEDDS preconcentrates were prepared, and 200 mg/g of each plant extract were suspended in these formulations. The 4-day suppressive Peter's test revealed a significant parasite growth inhibiting effect for all the extract-based SNEDDS (from 55.0 to 82.4 %) at 200 mg/kg. These activities were higher than those of their corresponding ethanolic suspensions given orally at the same dose (p<0.05). The combination therapy of MLSNEDDS with other extract-based SNEDDS exhibited remarkable chemosuppression, ranging from 74.3 % to 95.8 % (for 100 + 100 mg/kg) and 86.7 % to 95.5 % (for 200 + 200 mg/kg/day). In regard to these findings, SNEDDS suspension may constitute a promising approach for oral delivery of ML alone or in combination with other antimalarial plants.

Quinolinotriazole antiplasmodials via click chemistry: synthesis and in vitro studies of 7-Chloroquinoline-based compounds

Malaria is nowadays one of the most serious health concerns in a global scale and, although there is an evident increase in research studies in this area, pointed by the vast number of hits and leads, it still appears as a recurrent topic every year due to the drug resistance shown by the parasite exposing the urgent need to develop new antimalarial medications. In this work, 38 molecules were synthesized via copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) or "click" chemistry, following different routes to produce 2 different organic azides, obtained from a 4,7 dicholoquinoline, reacted with 19 different commercially available terminal alkynes. All those new compounds were evaluated for their in vitro activity against the chloroquine resistant malaria parasite Plasmodium falciparum (W2). The cytotoxicity evaluation was accomplished using Hep G2 cells and SI index was calculated for every molecule. Some of the quinoline derivatives have shown high antimalarial activity, with IC50 values in the range of 1.72-8.66 µM, low cytotoxicity, with CC50>1000 µM and selectivity index (SI) in the range of 20-100, with some compounds showing SI>800. Therefore, the quinolinotriazole hybrids could be considered a very important step on the development of new antimalarial drugs

Antimalarial activity of the aqueous extract of Euphorbia cordifolia Elliot in Plasmodium berghei-infected mice

Objective: To evaluate the antimalarial activity of the aqueous extract of Euphorbia (E.) cordifolia Elliot against Plasmodium (P.) berghei-infected mice. Methods: Thirty healthy Swiss mice were intraperitoneally inoculated with 200 μL of P. berghei parasitized-erythrocytes and divided into five groups, and then daily treated for 5 d with single dose of 10 mL/kg of distilled water for malaria control, 10 mg/kg of chloroquine for the chloroquine control and 100, 200 and 400 mg/kg of the aqueous extract of E. cordifolia for the three test groups. Parasitaemia was monitored by Giemsa-staining. At the end of the treatment, animals were sacrificed, and blood was collected for haematological and biochemical analyses. Organs were collected for biochemical and histopathological analyses. Statistical significance (P<0.05) was evaluated by analysis of variance followed by the Tukey post-test using Graphpad prism 7.0. Results: E. cordifolia extract decreased the parasite load to 2.46%, with an effective dose (ED50) of 113.07 mg/kg compared to the malaria group where the parasite load increased to (46.46±10.28)%. E. cordifolia extract prevented hypoglycaemia, anaemia, leucocytosis and thrombocytopenia, attenuated the increase of transaminases activities, bilirubin and creatinine rate, and improved catalase and superoxide dismutase activities, while reducing malondialdehyde contents in the liver and kidney. E. cordifolia extract significantly prevented histological damages observed in the malaria control group. No acute toxicity sign was observed in mice with plant extract at the dose up to 5 000 mg/kg. Conclusions: E. cordifolia extract at 200 and 400 mg/kg showed significant antimalarial effects. This results support its traditional use in the treatment of malaria.

ATP gatekeeper of Plasmodium protein kinase may provide the opportunity to develop selective antimalarial drugs with multiple targets

Malaria is one of the most devastating infectious diseases that caused millions of clinical cases annually despite decades of prevention efforts. Recent cases of Plasmodium falciparum resistance against the only remaining class of effective antimalarial (artemisinin) in South East Asia may soon pose a significant threat. Hence, the identification of new antimalarial compounds with a novel mode of action is necessary to curb this problem. Protein kinase has been implicated as a valid target for drug development in diseases such as cancer and diabetes in humans. A similar approach is now recognized for the treatment of protozoan-related disease including malaria. Few Plasmodium protein kinases that are not only crucial for their survival but also have unique structural features have been identified as a potential target for drug development. In this review, studies on antimalarial drug development exploiting the size of Plasmodium protein kinase ATP gatekeeper over the past 15 years are mainly discussed. The ATP-binding site of Plasmodium protein kinases such as Pf CDPK1, Pf CDPK4, Pf PKG, Pf PK7, and Pf PI4K showed great potential for selective and multi-target inhibitions owing to their smaller or unique ATP-gatekeeper amino acid subunits compared to that of human protein kinase. Hence it is a feasible solution to identify a new class of active antimalarial agents with a novel mode of action and longer clinical life-span.

Antimalarial activity of the aqueous extract of Euphorbia cordifolia Elliot in Plasmodium berghei-infected mice

Objective: To evaluate the antimalarial activity of the aqueous extract of Euphorbia (E.) cordifolia Elliot against Plasmodium (P.) berghei-infected mice. Methods: Thirty healthy Swiss mice were intraperitoneally inoculated with 200 μL of P. berghei parasitized-erythrocytes and divided into five groups, and then daily treated for 5 d with single dose of 10 mL/kg of distilled water for malaria control, 10 mg/kg of chloroquine for the chloroquine control and 100, 200 and 400 mg/kg of the aqueous extract of E. cordifolia for the three test groups. Parasitaemia was monitored by Giemsa-staining. At the end of the treatment, animals were sacrificed, and blood was collected for haematological and biochemical analyses. Organs were collected for biochemical and histopathological analyses. Statistical significance (P<0.05) was evaluated by analysis of variance followed by the Tukey post-test using Graphpad prism 7.0. Results: E. cordifolia extract decreased the parasite load to 2.46%, with an effective dose (ED

ATP gatekeeper of Plasmodium protein kinase may provide the opportunity to develop selective antimalarial drugs with multiple targets

Malaria is one of the most devastating infectious diseases that caused millions of clinical cases annually despite decades of prevention efforts. Recent cases of Plasmodium falciparum resistance against the only remaining class of effective antimalarial (artemisinin) in South East Asia may soon pose a significant threat. Hence, the identification of new antimalarial compounds with a novel mode of action is necessary to curb this problem. Protein kinase has been implicated as a valid target for drug development in diseases such as cancer and diabetes in humans. A similar approach is now recognized for the treatment of protozoan-related disease including malaria. Few Plasmodium protein kinases that are not only crucial for their survival but also have unique structural features have been identified as a potential target for drug development. In this review, studies on antimalarial drug development exploiting the size of Plasmodium protein kinase ATP gatekeeper over the past 15 years are mainly discussed. The ATP-binding site of Plasmodium protein kinases such as Pf CDPK1, Pf CDPK4, Pf PKG, Pf PK7, and Pf PI4K showed great potential for selective and multi-target inhibitions owing to their smaller or unique ATP-gatekeeper amino acid subunits compared to that of human protein kinase. Hence it is a feasible solution to identify a new class of active antimalarial agents with a novel mode of action and longer clinical life-span.

Antimalarial activity of a novel series of artemisinin-derived 1, 2, 3-triazole dimers

Objective: To obtain suitable artimisinin-based drug candidates with high antimalarial activity. Methods: Three different reaction schemes were used to synthesize a total of 15 artemisinin-based compounds. The first synthetic scheme involved the synthesis of diazido aliphatic and aromatic compounds from commercially available dihalides and azido derivatives of artemisinin. The second scheme consisted of the reaction of dibromoaliphatic compounds with sodium azide in dimethylformamide which yielded the desired compounds. Artemisinin-based compounds on treatment with sodium azide and bromotrimethylsilane in dichloromethane produced the most potent compound GB-2. Another potent compound GB-1 was synthesized from artemisinin by treatment with alcohols in the presence of Aberlyst-15 in anhydrous dichloromethane. The third scheme involved the Huisgen 1,3-dipolar cycloaddition between the synthesized aliphatic and aromatic diazides and two alkyne derivatives of artemisinin to obtain the desired artemisinin dimers with average yields. Results: The best in vitro antiplasmodial activity was shown by the compound GB-2 registering IC50 value 0.066 μg/mL against chloroquine-sensitive and 0.865 μg/mL against chloroquine-resistant strains of Plasmodium falciparum. It suppressed 59.0% parasitaemia in vivo of rodent malaria parasite Plasmodium berghei in Swiss albino model at 50 μg/kg body weight dosage. Molecular docking interactions of Plasmodium falciparum ATP6 (PfATP6) protein revealed strong bonding of GB-2 with Thr255 residue which is likely to be the reason for excellent antimalarial activity of this compound. Conclusion: Two compounds GB-1 and GB-2 exhibited excellent in vitro antiplasmodial activity and fair in vivo antimalarial activity. Of the two, GB-2 showed better activity which could be attributed to its strong bonding interactions with Thr255 as evidenced from the molecular docking study. Study helped in identifying artemisinin analogues possessing good antimalarial properties and further research in structural alterations of the selected molecules should be carried out which may result in obtaining potent drug candidates against the malarial parasite.

Antimalarial activity of a novel series of artemisinin-derived 1, 2, 3-triazole dimers

Objective: To obtain suitable artimisinin-based drug candidates with high antimalarial activity. Methods: Three different reaction schemes were used to synthesize a total of 15 artemisinin-based compounds. The first synthetic scheme involved the synthesis of diazido aliphatic and aromatic compounds from commercially available dihalides and azido derivatives of artemisinin. The second scheme consisted of the reaction of dibromoaliphatic compounds with sodium azide in dimethylformamide which yielded the desired compounds. Artemisinin-based compounds on treatment with sodium azide and bromotrimethylsilane in dichloromethane produced the most potent compound GB-2. Another potent compound GB-1 was synthesized from artemisinin by treatment with alcohols in the presence of Aberlyst-15 in anhydrous dichloromethane. The third scheme involved the Huisgen 1,3-dipolar cycloaddition between the synthesized aliphatic and aromatic diazides and two alkyne derivatives of artemisinin to obtain the desired artemisinin dimers with average yields. Results: The best in vitro antiplasmodial activity was shown by the compound GB-2 registering IC

Chemical Constituents of Hypericum uralum and the Analgesic and Antimalarial Activities / 中国药学杂志

OBJECTIVE: To study the chemical constituents of Hypericum uralum were isolated and identified and test the analgesic activity and β-hematin formation inhibitory activity of some selected compounds. METHODS: The compounds were isolated and purified by column chromatography padded with the separating material including silica gel and Sephadex LH-20, and their structures were elucidated based on the analyses of modern spectrum technology. Analgesic and antimalarial activities of selected compounds from H. uralum were evaluated by acetic acid-induced writhing, hot water tail-flick test in mice, and β-hematin formation inhibition method, respectively. RESULTS: Thirteen compounds were isolated from ethyl acetate portion of 95% ethanol extract of H. uralum and identified as (-)-eriodictyol (1), 3,4,5-trihydroxyxanthone (2), 1,7-dihydroxyxanthone (3), 4-hydroxy-2,3-dimethoxyxanthone (4), toxyloxanthone B (5), 1,3,6,7-tetrahydroxyxanthone (6), 2,3-dimethoxyxanthone (7), 1,5,6-trihydroxy-3-methoxyxanthone (8), hyperielliptone HD (9), 3,3′,4,4′-tetrahydroxybiphenyl (10), shikimic acid (11), quercetin-3-O-(4″-methoxy)-α-L-rahmnopyranosyl (12), and proanthocyanidin A-2 (13). The analgesic activity test indicated that compounds 3 and 12 had certain peripheral analgesic activity, while compound 1 exhibited strong β-hematin formation inhibitory activity. CONCLUSION: All the compounds are obtained from this plant for the first time.The analgesic and antimalarial activities of H. uralum have corresponding material basis.

Research progress of polyacetylenes from Bidens genus plants and their biological activity / 中草药

The genus Bidens (Compositae) are annual or perennial herbs distributed in tropical and subtropical regions. Many species of this genus are used in various folk medicines such as blood-pressure lowering and antihyperglycemic agents. As the characteristic components of plants in Bidens genus, polyacetylenes have attracted broad attention because of their antimalarial, hypoglycemic, antitumor and anti-inflammatory activities. In order to fully utilize the species of these medicinal plants, this paper reviewed the plant sources, type of the structure, and biological activity with view to providing the reference for the further researches and developments of polyacetylenes.

Ethnobotanical survey of antimalarial plants in Awash-Fentale District of Afar Region of Ethiopia and in vivo evaluation of selected ones against Plasmodium berghei

Objective:To document plants used in traditional treatment of malaria in the Awash-Fentale District,the Afar Region of Ethiopia,and to evaluate antimalarial activity of selected ones against Plasmodium berghei in mice.Methods:Semi-structured interviews were carried out with purposively selected informants in the District to gather information on plants used in the traditional treatment of malaria.Standard procedures were used to investigate acute toxicity and a four-day suppressive effect of cmde aqueous and ethanol extracts of the leaves of the two most frequently cited plants [Aloe trichosantha (A.trichosantha) and Cadaba rotundifolia (C.rotundifolia)] against Plasmodium berghei in Swiss albino mice.Results:The informants cited a total of 17 plants used in the traditional treatment of malaria in Awash-Fentale District.Plant parts were prepared as infusions or decoctions.Leaf was the most commonly cited (44％) plant part,followed by stem (22％).Shrubs were the most frequently cited (63％) medicine source followed by trees (21％).Of the 17 plants,C.rotundifolia and A.trichosantha were the most frequently mentioned plants in the district.Ethanol extracts of the leaves of C.rotundifolia and A.trichosantha suppressed P.berghei parasitaemia significantly accounting for 53.73％ and 49.07％,respectively at 900 mg/kg.The plants were found to be non-toxic up to a dose of 1 500 mg/kg.Conclusions:Seventeen plant species were reported to be used for treatment of malaria in the Awash Fentale Distinct,among which A.trichosantha and C.rotundifolia were the most preferred ones.P.berghei suppressive activity of these plants may partly explain their common use in the community.

Ethnobotanical survey of antimalarial plants in Awash-Fentale District of Afar Region of Ethiopia and in vivo evaluation of selected ones against Plasmodium berghei

Objective: To document plants used in traditional treatment of malaria in the Awash-Fentale District, the Afar Region of Ethiopia, and to evaluate antimalarial activity of selected ones against Plasmodium berghei in mice. Methods: Semi-structured interviews were carried out with purposively selected informants in the District to gather information on plants used in the traditional treatment of malaria. Standard procedures were used to investigate acute toxicity and a four-day suppressive effect of crude aqueous and ethanol extracts of the leaves of the two most frequently cited plants [Aloe trichosantha (A. trichosantha) and Cadaba rotundifolia (C. rotundifolia)] against Plasmodium berghei in Swiss albino mice. Results: The informants cited a total of 17 plants used in the traditional treatment of malaria in Awash-Fentale District. Plant parts were prepared as infusions or decoctions. Leaf was the most commonly cited (44%) plant part, followed by stem (22%). Shrubs were the most frequently cited (63%) medicine source followed by trees (21%). Of the 17 plants, C. rotundifolia and A. trichosantha were the most frequently mentioned plants in the district. Ethanol extracts of the leaves of C. rotundifolia and A. trichosantha suppressed P. berghei parasitaemia significantly accounting for 53.73% and 49.07%, respectively at 900 mg/kg. The plants were found to be non-toxic up to a dose of 1 500 mg/kg. Conclusions: Seventeen plant species were reported to be used for treatment of malaria in the Awash Fentale Distinct, among which A. trichosantha and C. rotundifolia were the most preferred ones. P. berghei suppressive activity of these plants may partly explain their common use in the community.

Molecular docking, synthesis and in vitro antimalarial evaluation of certain novel curcumin analogues

ABSTRACT The receptor protein PfATP6 has been identified as the common target of artemisinin and curcumin. The work was initiated to assess the antimalarial activity of six curcumin derivatives based on their binding affinities and correlating the in silico docking outcome with in vitro antimalarial screening results. A ligand library of thirty two Knoevenagel condensates of curcumin were designed and docked against PfATP6 protein and six compounds with the best binding scores were synthesized and screened for their antimalarial activity against the sensitive 3D7 strain of Plasmodium falciparum. ADME/Tox, pharmacokinetic and pharmacodynamic profiles of the designed compounds were analyzed and reported. 4-FB was found to have similar binding energy to the standard artemisinin (-6.75 and -6.73 respectively) while 4-MB, 3-HB, 2-HB, B, 4-NB displayed better binding energy than curcumin (-5.95, -5.89, -5.68, -5.35, -5.29 and -5.25 respectively). At a dose of 50 µg/mL all the six compounds showed 100% schizont inhibition while at 5µg/ml, five showed more than 75% inhibition and better results than curcumin. 4-FB showed the best activity with 97.8% schizonticidal activity. The in vitro results superimpose the results obtained from the in silico study thereby encouraging development of promising curcumin leads in the battle against malaria.

Antimalarial Activity of C-10 Substituted Triazolyl Artemisinin

We synthesized C-10 substituted triazolyl artemisinins by the Huisgen cycloaddition reaction between dihydroartemisinins (2) and variously substituted 1, 2, 3-triazoles (8a-8h). The antimalarial activities of 32 novel artemisinin derivatives were screened against a chloroquine-resistant parasite. Among them, triazolyl artemisinins with electron-withdrawing groups showed stronger antimalarial activities than those shown by the derivatives having electron-donating groups. In particularly, m-chlorotriazolyl artemisinin (9d-12d) showed antimalarial activity equivalent to that of artemisinin and could be a strong drug candidate.

Optimized Artemether-loaded Anhydrous Emulsion.

Objective: The objectives of this study were to identify stable anhydrous emulsions via pseudo ternary phase diagram, optimize artemether-loaded batches using factorial design and subsequently evaluate the antimalarial activity. Methodology: Using labrasol®, triacetin® and lauroglycol 90® as the surfactant, oil and co-surfactant respectively, pseudo ternary phase diagram was generated from the quantitative titration of water with the anhydrous emulsion. Stable combinations from the phase diagram were subjected to a 23 full factorial experimental design. The 22 softwaregenerated formulations were experimentally formulated and characterized for droplet size, polydispersity index, viscosity and thermodynamic stability. Droplet size was chosen and subsequently fitted into the Response column of the software, thus prompting the generation of graphs and Desirability table of 125 predicted formulations. Out of the 125 predictions, three with the least droplet sizes (less than 100 nm) were adjudged as optimized batches. Subsequently, they were formulated, converted to powder by adsorption on magnesium aluminum metasilicate and evaluated. Antimalarial effectiveness of the drug-loaded formulation was also investigated. Results: Triacetin® most significantly (P<0.05) contributed to droplet size variation. The droplet size of the experimental formulations approximated that of the statistical predictions. The anhydrous emulsions (AEs) were powderable and the granulations rated fair and passable according to Carr’s scale. Artemether-loaded anhydrous emulsion (AE) demonstrated highest antimalarial activity. Conclusion: We therefore conclude that optimization proved a useful tool for the identification of excipient proportions with optimal effects.

Antileishmanial, Antimalarial and Antimicrobial activity of the Jamaican ‘Touch-me-not’ sponge Neofibularia nolitangere.

The crude extracts and fractions of the Jamaican sponge Neofibularia nolitangere were examined for biological activity. The dried animal was extracted successively in three organic solvents (hexane, methylene chloride and methanol) and tested for their potential as antileishmanial, antimalarial and antimicrobial agents. Fractions of the crude methylene chloride extract demonstrated notable antimalarial properties giving percentage inhibitions of 87% and 78% respectively for fractions Y4 and Y5 at 20 μg/mL. Fractions Y4 and Z4 showed remarkable antileishmanial activity inhibiting the growth of the pathogen by 93.31% and 91.77% respectively at 20 μg/mL. No significant activity was observed in the antimicrobial assays.

In vitro antimalarial activity of extracts of some plants from a biological reserve in Costa Rica

Treatment with the usual antimalarial drugs, have induced parasite resistance, reinforcing the need to finding natural antimalarial components that would be found on plants from the forest. Therefore, we decided to look for these components in Costa Rican plants from a protected forest area. Fresh and dry extracts of roots, bark, leaves, flowers and fruits of 25 plants from a biological reserve in Costa Rica, Reserva Biológica Alberto Manuel Brenes (REBAMB), were studied in vitro for the presence of substances with antimalarial activity. By studying the inhibition of P. berghei schizogony, we assessed the antimalarial activity of several plant extracts: Aphelandra aurantiaca, A. tridentata (Acanthaceae); Xanthosoma undipes (Araceae); Iriartea deltoidea (Arecaceae); Neurolaena lobata (Asteraceae); Senna papillosa, Pterocarpus hayessi, Lonchocarpus pentaphyllus (Fabaceae); Nectandra membranacea, Persea povedae, Cinamomum chavarrianum (Lauraceae); Hampea appendiculata (Malvaceae); Ruagea glabra, Guarea glabra (Meliaceae); Psidium guajava (Myrtaceae); Bocconia frutescens (Papaveraceae); Piper friedrichsthalii (Piperaceae); Clematis dioica (Ranunculaceae); Prunus annularis (Rosaceae); Siparuna thecaphora (Siparunaceae); Solanum arboreum, Witheringia solanácea (Solanaceae); Ticodendrum incognitum (Ticodendraceae); Heliocarpus appendiculatus (Tiliaceae) and Myriocarpa longipes (Urticaceae). We used different parts of the plants as well as fresh and dried extracts for testing IC50. The solid content of the extracts ranged from 1-71.9μg/mL. The fresh extracts showed stronger activity than the dry ones. Since the plants showing the strongest antimalarial activity are very common in Central America, and some similar genera of these plants have shown positives results in South America, we considered important to present these findings for discussion. On the other hand, this is the first systematic study of this kind ever realized in a circumscribed and protected area of Costa Rica. Rev. Biol. Trop. 60 (2): 881-891. Epub 2012 June 01.

El tratamiento con las drogas antimaláricas de uso común han inducido resistencia por parte del parásito, lo que obliga a buscar en las plantas de los bosques, componentes naturales con actividad en contra de esta enfermedad. Por lo tanto, decidimos buscar dichos componentes en plantas de una Reserva Forestal de Costa Rica. Extractos tanto frescos como secos de raíz, corteza, hojas, flores y frutos, de 25 plantas de la Reserva Biológica Alberto Manuel Brenes (REBAMB), fueron estudiados in vitro en busca de sustancias con actividad antimalárica. Las plantas estudiadas fueron: Aphelandra aurantiaca, A. tridentata (Acanthaceae); Xanthosoma undipes (Araceae); Iriartea deltoidea (Arecaceae); Neurolaena lobata (Asteraceae); Senna papillosa, Pterocarpus hayessi, Lonchocarpus pentaphyllus (Fabaceae); Nectandra membranacea, Persea povedae, Cinamomum chavarrianum (Lauraceae); Hampea appendiculata (Malvaceae); Ruagea glabra, Guarea glabra (Meliaceae); Psidium guajava (Myrtaceae); Bocconia frutescens (Papaveraceae); Piper friedrichsthalii (Piperaceae); Clematis dioica (Ranunculaceae); Prunus annularis (Rosaceae); Siparuna thecaphora (Siparunaceae); Solanum arboreum, Witheringia solanacea (Solanaceae); Ticodendrum incognitum (Ticodendraceae); Heliocarpus appendiculatus (Tiliaceae) y Myriocarpa longipes (Urticaceae). Los extractos frescos y secos de las diferentes partes de las plantas fueron estudiadas y se determinó la IC50, el cual osciló entre 1-71.9mg/mL; los extractos frescos mostraron mayor actividad antimalárica. Las plantas que presentaron mayor actividad son muy comunes en Centroamérica y algunos géneros similares, aunque no las mismas especies, han sido encontrados positivos en América del Sur; por esta razón consideramos importante estos resultados como información y materia de discusión en este tema. Además este es el primer estudio sistemático de esta naturaleza realizado en un área boscosa circunscrita y protegida de Costa Rica.

Antiplasmodial and antiulcer activities of Melanthera scadens

<p><b>OBJECTIVE</b>To evaluate the antimalarial and antiulcerogenic activities of leaf extract and fractions of Melanthera scandens (M. scandens).</p><p><b>METHODS</b>The crude leaf extract (37-111 mg/kg) and fractions (chloroform, ethylacetate and methanol; 78 mg/kg) of M. scadens were investigated for antiplasmodial activity against chloroquine-sensitive Plasmodium berghei infections in mice and for antiulcer activity against experimentally-induced ulcers. The antimalarial activity during early and established infections as well as prophylactic was investigated. Artesunate (5 mg/kg) and pyrimethamine (1.2 mg/kg) were used as positive controls. Thin films made from tail blood of each mouse were used to assess the level of parasitaemia of the mice. Antiulcer activity of the crude extract was also evaluated against indomethacin, ethanol and histamine induced ulcers.</p><p><b>RESULTS</b>The extract and its fractions dose-dependently reduced parasitaemia induced by chloroquine-sensitive Plasmodium berghei infection in prophylactic, suppressive and curative models in mice. These reductions were statistically significant (P<0.001). They also improved the mean survival time (MST) from 9.28 to 17.73 days as compared with the control (P<0.01-0.001). The activities of extract/fractions were incomparable to that of the standard drugs i.e. artesunate and pyrimethamine. On experimentally-induced ulcers, the extract inhibited indomethacin, ethanol and histamine induced ulcers. These inhibitions were statistically significant (P<0.001) and in a dose-dependent fashion.</p><p><b>CONCLUSIONS</b>The antiplasmodial and antiulcerogenic effects of this plant may in part be mediated through the chemical constituents of the plant.</p>

Actividad antimalárica de un extracto hidroalcohólico de Bixa orellana L. / Antimalarial activity of hydroalcoholic extract from Bixa orellana L.

Introducción: Bixa orellana L. es una especie usada en la medicina tradicional de países de diversos continentes. Entre las propiedades medicinales que se le atribuyen se incluye su acción antimalárica. Objetivo: evaluar la actividad antimalárica in vitro e in vivo de un extracto de B. orellana cultivada en Cuba. Métodos: la actividad antimalárica del extracto hidroalcohólico de semillas de Bija se evaluó in vitro frente a la cepa Ghana de Plasmodium falciparum e in vivo utilizando un modelo de malaria de roedores, ratones Balb/c infectados con la cepa ANKA de Plasmodium berghei. La citotoxicidad se determinó frente a fibroblastos humanos de la línea MRC-5. Además, se caracterizó preliminarmente la composición fitoquímica del extracto estudiado. Resultados: el extracto exhibió un valor de concentración inhibitoria media de 11,6 µg/mL, concentración citotóxica media de 60,2 µg/mL e índice de selectividad de 5,1. La administración subcutánea del extracto a la dosis de 500 mg/kg causó una reducción de 50,3 ± 5,8 por ciento de la parasitemia en los animales infectados en comparación con la observada en los controles. El tamizaje fitoquímico fue consistente con la detección de triterpenoides y(o) esteroides, alcaloides, compuestos lactónicos, compuestos fenólicos, taninos y flavonoides. Conclusiones: el extracto hidroalcohólico de semillas de B. orellana cultivada en Cuba mostró actividad antimalárica moderada tanto in vitro como in vivo. El fraccionamiento guiado por bioensayos permitiría identificar las moléculas responsables de la actividad demostrada por este extracto y reevaluar sus potencialidades.

Introduction: Bixa orellana L. is one species used in traditional herb medicine in several continents. Among the medicinal properties attributed to this plant, the antimalarial action has been included. Objective: to evaluate in vitro and in vivo antimalarial activity of extract from B. orellana grown in Cuba. Methods: the antimalarial activity of the hydroalcoholic extract fro Bija seeds was evaluated in vitro against Plasmodium falciparum Ghana strain and in vivo using a model of murine malaria, that is, Balb/c mice infected with Plasmodium berghei ANKA strain. Citotoxicity was determined against MRC-5 human fibroblasts. Additionally, phytochemical composition of the studied extract was preliminarily informed. Results: the extract exhibited IC50 (Medium Inhibitory Concentration) of 11.6 µg/mL, CC50 (Medium Citotoxic Concentration) of 60.2 µg/mL and SI (Selectivity Index) of 5.1. Subcutaneous administration of the extract at a 500 mg/kg dose caused parasitemia reduction of 50.3 ± 5.8 percent on infected animals compared with that of the controls. Phytochemical screening was consistent with detection of triterpenoids and/or steroids, alkaloids, lactonic compounds, phenols, tanins and flavonoids. Conclusions: the hydroalcoholic extract from B. orellana seeds grown in Cuba showed in vitro and in vivo moderate antimalarial activity. Bioassay-guided fractioning will allow identifying the molecules responsible for the exhibited extract activity and re-evaluating the potentialities of this extract.

Actividad antimalárica y citotoxicidad de extractos hidroalcohólicos de seis especies de plantas usadas en la medicina tradicional cubana / Antimalarial activity and cytotoxicity of hydroalcoholic extracts from six plant species used in Cuban traditional medicine

INTRODUCCIÓN: la malaria es la enfermedad parasitaria de mayor importancia para la salud mundial. La carencia de diversidad estructural de los antimaláricos en uso convierte en una necesidad urgente la búsqueda de nuevas alternativas terapéuticas. Las plantas han demostrado su potencial para proveer antimaláricos efectivos. Una amplia muestra de plantas medicinales cubanas están siendo estudiadas con este propósito. OBJETIVO: evaluar la actividad antimalárica de extractos de 6 especies de plantas y determinar su selectividad midiendo la citotoxicidad frente a células humanas. MÉTODOS: se prepararon extractos hidroalcohólicos de partes aéreas de: Annona glabra L., Bidens pilosa L., Cecropia peltata L., Curcuma longa L., Hura crepitans L. y Pluchea odorata (L.) Cass. La actividad de los extractos se evaluó in vitro frente a Plasmodium falciparum y fibroblastos humanos MRC-5. Se calcularon la concentración inhibitoria media, concentración citotóxica media y el índice de selectividad. Se realizó un tamizaje fitoquímico preliminar del extracto más activo. RESULTADOS: solo el extracto de H. crepitans mostró buena actividad antiplasmodial (concentración inhibitoria media de 5,7 µg/mL) con excelente selectividad (índice de selectividad de 18,8). El tamizaje fitoquímico reveló la presencia de compuestos fenólicos, triterpenoides, alcaloides, quinonas, flavonoides y antocianidinas. CONCLUSIONES: se obtuvo un extracto con potente actividad antimalárica in vitro. Este resultado induce a continuar estudiando esta preparación vegetal.

INTRODUCTION: malaria is the most important parasitic disease for global health. Lack of the structural diversity in current antimalarials demands the urgent search for new therapeutic alternatives. The plants have shown their potential to provide effective antimalarials, therefore, a large sample of Cuban medicinal plants is being studied. OBJECTIVES: to evaluate antimalarial activity of extracts from six plant species and to determine their selectivity by meassuring cytotoxicity against human cells. METHODS: hydroalcoholic extracts from Annona glabra L., Bidens pilosa L., Cecropia peltata L., Curcuma longa L., Hura crepitans L. and Pluchea odorata (L.) Cass. were prepared. Their activity was evaluated in vitro against Plasmodium falciparum and human fibroblasts MRC-5. The mean inhibitory concentration, the mean cytotoxic concentration and the selectivity index were estimated. A preliminary phytochemical screening of the most active extract was made. RESULTS: H. crepitans extract was the only one that showed good antiplasmodial activity (mean inhibitory concentration of 5.7 µg/mL) with excellent selectivity (selectivity index of 18.8). Phytochemical screening revealed the presence of phenolic compounds, triterpenoids, alkaloids, quinones, flavonoids and anthocyanidins. CONCLUSIONS: one extract with potent antimalarial activity in vitro was obtained. This result is an incentive to continue studying this vegetal preparation.